|
|
Volumn 15, Issue 12, 1997, Pages 1240-
|
|
Enbrel’s phase III reinforces prospects in RA
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COLLAGEN;
INTERLEUKIN 10;
INTERLEUKIN 4;
MONOCLONAL ANTIBODY;
PLACEBO;
RECOMBINANT PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
ARTICLE;
DRUG ANTAGONISM;
HUMAN;
PHASE 3 CLINICAL TRIAL;
RHEUMATOID ARTHRITIS;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS, PHASE III;
COLLAGEN;
HUMANS;
INTERLEUKIN-10;
INTERLEUKIN-4;
PLACEBOS;
RECEPTORS, TUMOR NECROSIS FACTOR;
RECOMBINANT PROTEINS;
|
|
EID: 0031279920
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1197-1240 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|